CTMS Software, Reimagined: Inside Trial Interactive's Version 3.2

Every clinical trial team knows the moment. A milestone date shifts, and nobody can say why, or what the original plan looked like. A protocol amendment takes effect in one country while others still work from the prior version. A vendor relationship that matters to several studies lives in someone's inbox instead of anywhere the whole team can see it. These are not dramatic failures. They’re small cracks that widen as a trial scales, and they’re exactly what Trial Interactive CTMS software was built to close.

With the upcoming CTMS 3.2 release, Trial Interactive is doubling down on that mission, focusing on four connected themes: milestone tracking, protocol and ICF management, global activity visibility, and a more unified platform experience. Together, these enhancements give study teams greater visibility, improved operational control, and a more connected experience across their clinical operations.

Milestone Tracking That Keeps Timelines Honest

Trial timelines rarely unfold exactly as planned, and pretending otherwise has always been the quiet flaw in traditional milestone tracking. CTMS 3.2 introduces a formal re-baselining framework that captures the Initial Baseline Date and the Re-Baseline Date separately, preserving the original plan even as the schedule evolves. Teams can log the reason behind date changes, compare planned versus actual timelines, and receive automated notifications as milestones approach or pass their due dates. Paired with custom views and filters, this milestone tracking capability turns a manual process into a transparent, auditable one, giving sponsors and CROs a clearer understanding of how study timelines evolve.

Protocol and ICF Version Control Across Every Site

Few things carry more compliance weight than ensuring a subject consents to the correct, current protocol version. Yet across a global study, protocol version control has often meant spreadsheets, side conversations, and hope. CTMS 3.2 replaces that patchwork with a unified framework that tracks protocol versions at the study, country, and site levels, with direct linkage to the corresponding Informed Consent Forms at each level. Teams can designate the current version, track effective dates, map relationships between ICFs across the study hierarchy, and capture comments, all visible in one consolidated list. The result is fewer protocol deviations, simpler inspection readiness, and one less disconnected tool to manage. That level of protocol version control turns a compliance requirement into a routine, defensible part of daily work.

Global Activity Visibility Beyond the Study Level

Clinical operations extend beyond the boundaries of a single study. Organizations, contacts, vendors, investigators, and other key stakeholders often support multiple studies simultaneously; however, tracking their activities has traditionally required spreadsheets or separate systems outside the CTMS. CTMS 3.2 changes that by enabling teams to create and manage activities directly at the global organization and contact level, independent of any individual study. A new centralized Activities Roll-Up View provides visibility into activities across studies and global entities from a single location, giving clinical operations teams a more complete picture of ongoing work. By centralizing activity tracking, teams can improve collaboration, enhance data quality, reduce duplicate activity tracking, and ensure important activities are visible wherever they matter.

One Connected Platform, One Consistent Experience

Clinical operations rarely rely on a single application. Study teams move between CTMS, eTMF, and other Trial Interactive applications throughout the day, making a consistent user experience essential. CTMS 3.2 introduces a more unified platform experience with aligned navigation, centralized application access, consistent branding, and streamlined access to user settings and resources. Together with usability enhancements such as collapsible dashboards and in-record workflow claiming, these improvements create a more intuitive experience while establishing the foundation for an increasingly connected Trial Interactive platform.

Taken together, CTMS 3.2 reflects Trial Interactive's continued investment in helping study teams manage increasingly complex clinical trials with greater visibility, enhanced data integrity, and a more connected user experience. From milestone planning and protocol management to global activity tracking and a unified platform experience, these enhancements help organizations spend less time managing processes and more time advancing their studies.

Curious what CTMS 3.2 could mean for your next study? Reach out to the Trial Interactive team to see it in action.